MissionIR Articles
-
Lantos Affirms Support of Expanded Stem Cell Research — Applauds Commitment by VistaGen Employees and Investors
Congressman Tom Lantos (D-San Francisco, San Mateo) speaking from the laboratories of VistaGen Therapeutics, a biopharmaceutical company, affirmed his support of the expansion of stem cell research using human embryos that would otherwise become medical…
-
VistaGen Therapeutics Secures Development Support for New Drug Candidate forHuntington’s Disease
VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics using embryonic stem cell technologies, announced today that the High Q Foundation, Inc. has agreed…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Engages Tetra Tech, GeoSim for Sarfartoq S-K 1300 Resource Update
- MindWave Innovations Inc. (NYSE American: APUS) Is Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management
- MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform
- MissionIRNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine
- MissionIRNewsBreaks – VolitionRx (NYSE American: VNRX) Collaborates with Sysmex to Advance Nu.Q® NETs Assay Development